€1.9 million for mRNA technology RIBOPRO

RIBOPRO is focusing on biotech and biopharma through the co-creation of innovative mRNA drugs based on patented mRNA technologies. The start-up secured a €1.9 million convertible loan last week. The convertible loan comes from existing investors Vlasroot, BOM, the Fredriks…